Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (380) Glyburide Tablets, Mova Pharmaceutical,
...Newly Approved Drug Therapies (380) Glyburide Tablets, Mova Pharmaceutical, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Glyburide Tablets Company: Mova Pharmaceutical Approval Status: Approved December 1997 Treatment Area: blood-glucose lowering agent ...
View Page

2.  Newly Approved Drug Therapies (451) Glyburide Tablets, Mylan Laboratories,
...Newly Approved Drug Therapies (451) Glyburide Tablets, Mylan Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Glyburide Tablets Company: Mylan Laboratories Approval Status: Approved July 1998. Treatment Area: Diabetes Mellitus General Information ...
View Page

3.  Study Posting (4519) Trial #111876, Diabetes Mellitus, Type 2, Honolulu, HI
...2, Honolulu, HI Trial Information A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Status: Completed Protocol Number: NP20194 Sponsor: Hoffmann-La Roche ...
...An open-label, crossover study to investigate the potential pharmacodynamic and potential pharmacokinetic interaction between glyburide and GK Activator(2) in type 2 diabetes patients inadequately controlled with glyburide as standard ...
View Page

4.  Study Posting (4519) Trial #112542, Diabetes Mellitus, Type 2, Cypress, CA
...2, Cypress, CA Trial Information A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Status: Completed Protocol Number: NP20194 Sponsor: Hoffmann-La Roche ...
...An open-label, crossover study to investigate the potential pharmacodynamic and potential pharmacokinetic interaction between glyburide and GK Activator(2) in type 2 diabetes patients inadequately controlled with glyburide as standard ...
View Page

5.  Study Posting (4519) Trial #111466, Diabetes Mellitus, Type 2, San Antonio, TX
...San Antonio, TX Trial Information A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Status: Completed Protocol Number: NP20194 Sponsor: Hoffmann-La Roche ...
...An open-label, crossover study to investigate the potential pharmacodynamic and potential pharmacokinetic interaction between glyburide and GK Activator(2) in type 2 diabetes patients inadequately controlled with glyburide as standard ...
View Page

6.  Newly Approved Drug Therapies (379) Glyburide Tablets, Roche,
...Newly Approved Drug Therapies (379) Glyburide Tablets, Roche, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Glyburide Tablets Company: Roche Approval Status: Approved December 1997 Treatment Area: blood-glucose lowering agent General ...
View Page

7. Clinical Trial Results by Drug Names
...Result Information Title of Study: A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Fast Facts: Protocol number: NP20194 Sponsor: Hoffmann-La Roche ...
View Page

8.  Study Posting (1150) Trial #153266, Diabetes Mellitus, Type 2, Redlands, CA
...antidiabetes medications: • Glucophage® (metformin) • Actos® (pioglitazone HCI) • Avandia® (rosiglitazone maleate) • Sulfonylurea medication, such as: • DiaBeta® (glyburide) • Amaryl® (glimepiride) • Still unable to control your blood sugar Volunteers may receive, at no cost ...
View Page

9.  Study Posting (3333) Trial #59679, Diabetes Mellitus, Type 2, Anaheim, CA
...75. You may be naïve or treating your diabetes with at least 10 mg of glyburide for at least two weeks. As part of the study, you will receive: • Study-related ...
View Page

10.  Newly Approved Drug Therapies (370) Prandin, Novo Nordisk,
...to sulfonylureas, but there was a slightly higher incidence of cardiovascular events when compared with glyburide. Mechanism of Action Prandin stimulates insulin secretion from the beta cells of the pancreas by ...
View Page

11.  Newly Approved Drug Therapies (1042) Onglyza (saxagliptin), Bristol-Myers Squibb,
...approval of Onglyza was based on monotherapy trials and in trials combining Onglyza with metformin, glyburide, and thiazolidinedione (pioglitazone and rosiglitazone) therapy. Monotherapy A total of 766 subjects with type II ...
...corrected reduction of 0.4%). Combination Therapy In trials evaluating Onglyza in combination with metformin, glyburide, and thiazolidinedione (pioglitazone and rosiglitazone), Onglyza 2.5 mg and 5 mg plus combination provided ...
View Page

12.  CenterWatch: List of Newly Approved Drug Thearapies
...brain cancer, Approved February 1997 Glipizide Tablets ; Duramed Pharmaceuticals; Treatment for diabetes, Approved September 1997 Glyburide Tablets ; Roche; Treatment for blood-glucose lowering, Approved December 1997 Glyburide Tablets ; Mova Pharmaceutical; Generic version of Glynase PresTab, Approved December 1997 Gonal-F (follitropin alfa ...
View Page

13. Advanced/Specific Search Results GK Activator (2)
...To be Published Phase: I A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Product Name: GK Activator (2) Date of Report: To ...
View Page

14.  Newly Approved Drug Therapies (528) Avandia (rosiglitazone maleate), SmithKline Beecham,
...six double-blind studies, which included two 26-week placebo-controlled studies, one 52-week glyburide-controlled study, and three placebo-controlled dose-ranging studies of 8 to 12 weeks duration ...
View Page

15.  CenterWatch: Hematology Approved Drug Therapies
...1997 BeneFIX (coagulation Factor IX (recombinant)) ; Genetics Institute; Treatment for hemophilia B, Approved February 1997 Glyburide Tablets ; Roche; Treatment for blood-glucose lowering, Approved December 1997 Glyburide Tablets ; Mova Pharmaceutical; Generic version of Glynase PresTab, Approved December 1997 Lovenox (enoxaparin sodium) Injection ...
View Page

16.  CenterWatch: Endocrinology Approved Drug Therapies
...with diabetes., Approved October 1998 Glucagon ; Eli Lilly; Treatment for severe Hypoglycemia, Approved September 1998 Glyburide Tablets ; Mylan Laboratories; Treatment for Diabetes Mellitus (Type II), Approved July 1998. Herceptin ; Genentech; Treatment ...
...brain cancer, Approved February 1997 Glipizide Tablets ; Duramed Pharmaceuticals; Treatment for diabetes, Approved September 1997 Glyburide Tablets ; Roche; Treatment for blood-glucose lowering, Approved December 1997 Glyburide Tablets ; Mova Pharmaceutical; Generic ...
View Page

17.  CenterWatch: Clinical Trials in Category (603) Diabetes Mellitus, Type 2
...proglitazone) only. Cypress : Research Site: A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Cypress : Research Site: A Study of the Effect of ...
...Glargine Hawaii Honolulu : Research Site: A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Idaho Boise : Northwest Clinical Trials, Inc. A study for ...
View Page

18.  CenterWatch: List of Newly Approved Drug Thearapies
...with diabetes., Approved October 1998 Glucagon ; Eli Lilly; Treatment for severe Hypoglycemia, Approved September 1998 Glyburide Tablets ; Mylan Laboratories; Treatment for Diabetes Mellitus (Type II), Approved July 1998. Herceptin ; Genentech; Treatment ...
View Page

19. Clinical Trial Results: Diabetes Mellitus, Type 2
...To be Published Phase: I A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. Product Name: GK Activator (2) Date of Report: To ...
View Page